“…All along, calnexin works in partnership with ERp57, an oxidoreductase that is a member of the protein disulfide isomerase (PDI) family (Coe and Michalak, 2010;Oliver et al, 1997;Zapun et al, 1998). Studies have shown that a certain subset of disulfide-bonded heavily glycosylated proteins such as the lowdensity lipoprotein receptor (LDLR) depend specifically on this partnership for efficient folding and subsequent trafficking through the secretory system (Jessop et al, 2007;Rutkevich and Williams, 2011). Surprisingly, our laboratory and others have determined that calnexin is not only found on the rough ER, but is often enriched on the MAM (Hayashi and Su, 2007;Myhill et al, 2008;Wieckowski et al, 2009).…”